StockNews.com downgraded shares of LeMaitre Vascular (NASDAQ:LMAT – Free Report) from a buy rating to a hold rating in a research note released on Thursday morning.
Other equities research analysts have also issued reports about the stock. Oppenheimer assumed coverage on shares of LeMaitre Vascular in a report on Tuesday. They set an outperform rating and a $70.00 price target for the company. Lake Street Capital increased their price objective on shares of LeMaitre Vascular from $65.00 to $75.00 and gave the company a buy rating in a research note on Wednesday, August 2nd. Barrington Research increased their price objective on shares of LeMaitre Vascular from $62.00 to $66.00 and gave the company an outperform rating in a research note on Wednesday, August 2nd. Finally, Jefferies Financial Group downgraded shares of LeMaitre Vascular from a buy rating to a hold rating and increased their price objective for the company from $63.00 to $67.00 in a research note on Thursday, August 3rd. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of Moderate Buy and a consensus target price of $69.50.
Get Our Latest Analysis on LeMaitre Vascular
LeMaitre Vascular Trading Up 0.6 %
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) last released its quarterly earnings results on Tuesday, August 1st. The medical instruments supplier reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.32 by $0.05. The business had revenue of $50.12 million during the quarter, compared to analyst estimates of $48.29 million. LeMaitre Vascular had a net margin of 14.23% and a return on equity of 9.33%. On average, analysts forecast that LeMaitre Vascular will post 1.3 earnings per share for the current fiscal year.
LeMaitre Vascular Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, August 31st. Stockholders of record on Thursday, August 17th were given a $0.14 dividend. The ex-dividend date was Wednesday, August 16th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.98%. LeMaitre Vascular’s payout ratio is currently 49.56%.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the business. Harbor Capital Advisors Inc. bought a new position in shares of LeMaitre Vascular in the 2nd quarter worth about $26,000. Altshuler Shaham Ltd bought a new position in shares of LeMaitre Vascular in the 2nd quarter worth about $29,000. Captrust Financial Advisors lifted its position in shares of LeMaitre Vascular by 555.3% in the 1st quarter. Captrust Financial Advisors now owns 616 shares of the medical instruments supplier’s stock worth $29,000 after buying an additional 522 shares during the last quarter. FMR LLC lifted its position in shares of LeMaitre Vascular by 111.7% in the 1st quarter. FMR LLC now owns 633 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 334 shares during the last quarter. Finally, Pacer Advisors Inc. bought a new position in shares of LeMaitre Vascular in the 2nd quarter worth about $39,000. 84.64% of the stock is currently owned by institutional investors.
About LeMaitre Vascular
LeMaitre Vascular, Inc designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system.
Read More
- Five stocks we like better than LeMaitre Vascular
- Space Investment: How to Invest in Space Exploration
- These 3 Wood Stocks are about to go on Discount
- How to Invest in Hotel Stocks
- Same Coin, Different Sides: 2 Observability Stocks Reverse Ways
- How to Invest in Lithium and Lithium Stocks
- 3 Stocks Awaiting Winter Winds of Opportunity
Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.
